Berkeley Lights, Inc.
Mutant IDH1 Specific T Cell Receptor
Last updated:
Abstract:
This disclosure relates to the production and use of an isolated, purified and/or recombinant T cell receptor (TCR) that specifically binds to a mutant IDH1 protein, or a fragment thereof, wherein the mutant IDH1 protein or fragment thereof comprises an R132H mutation.
Status:
Application
Type:
Utility
Filling date:
7 Aug 2020
Issue date:
25 Mar 2021